| Dr Patricia L Fisher, MD | |
|
617 Riverside Ave, Burlington, VT 05401-1601 | |
| (802) 864-6309 | |
| (802) 860-4324 |
| Full Name | Dr Patricia L Fisher |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 25 Years |
| Location | 617 Riverside Ave, Burlington, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053397570 | NPI | - | NPPES |
| 59784 | Other | VT | BLUE CROSS BLUE SHIELD |
| 1010219 | Medicaid | VT | |
| 4661403 | Other | VT | FLETCHER ALLEN PREFERRED |
| 364345 | Other | VT | MVP |
| 59784 | Other | VT | VERMONT MANAGED CARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 04200106644 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ocean Medical Center | Brick, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Plover Inpatient Services Llc | 1355561663 | 112 |
News Archive
Anyone doubting the commitment of business to compliance and ethics will be surprised by the findings of a survey which reveals spending on compliance has remained stronger than anticipated. Roughly three out of four companies either kept compliance spending even or actually increased it in 2009, and for 2010 the prognosis is even brighter.
K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market CAYMAN Minimally Invasive, the latest addition to the company's CAYMAN product family of plate systems already featuring CAYMAN Anterior, CAYMAN Buttress and CAYMAN Lateral.
Five Prime Therapeutics, Inc., a leader in biologics, has relocated into its state-of-the-art drug discovery facility in South San Francisco. The new facility provides FivePrime with a two fold increase in square footage without significant incremental rental cost. The relocation includes an expanded laboratory facility for the Company to accelerate its innovative and proprietary protein therapeutic and antibody drug discovery platform.
Using a molecular cellular compass, individual cells in complex organisms know which way is up or down, in epithelial cells known as apical-basal polarity.
Analysis of the gut microbiome more successfully distinguished healthy individuals from those with precancerous adenomatous polyps and those with invasive colorectal cancer compared with assessment of clinical risk factors and fecal occult blood testing, according to data published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
› Verified 2 days ago
| Entity Name | Plover Inpatient Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134534688 PECOS PAC ID: 1355561663 Enrollment ID: O20141009001113 |
News Archive
Anyone doubting the commitment of business to compliance and ethics will be surprised by the findings of a survey which reveals spending on compliance has remained stronger than anticipated. Roughly three out of four companies either kept compliance spending even or actually increased it in 2009, and for 2010 the prognosis is even brighter.
K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market CAYMAN Minimally Invasive, the latest addition to the company's CAYMAN product family of plate systems already featuring CAYMAN Anterior, CAYMAN Buttress and CAYMAN Lateral.
Five Prime Therapeutics, Inc., a leader in biologics, has relocated into its state-of-the-art drug discovery facility in South San Francisco. The new facility provides FivePrime with a two fold increase in square footage without significant incremental rental cost. The relocation includes an expanded laboratory facility for the Company to accelerate its innovative and proprietary protein therapeutic and antibody drug discovery platform.
Using a molecular cellular compass, individual cells in complex organisms know which way is up or down, in epithelial cells known as apical-basal polarity.
Analysis of the gut microbiome more successfully distinguished healthy individuals from those with precancerous adenomatous polyps and those with invasive colorectal cancer compared with assessment of clinical risk factors and fecal occult blood testing, according to data published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Patricia L Fisher, MD 900 Dorset St, South Burlington, VT 05403-7502 Ph: (802) 864-6309 | Dr Patricia L Fisher, MD 617 Riverside Ave, Burlington, VT 05401-1601 Ph: (802) 864-6309 |
News Archive
Anyone doubting the commitment of business to compliance and ethics will be surprised by the findings of a survey which reveals spending on compliance has remained stronger than anticipated. Roughly three out of four companies either kept compliance spending even or actually increased it in 2009, and for 2010 the prognosis is even brighter.
K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market CAYMAN Minimally Invasive, the latest addition to the company's CAYMAN product family of plate systems already featuring CAYMAN Anterior, CAYMAN Buttress and CAYMAN Lateral.
Five Prime Therapeutics, Inc., a leader in biologics, has relocated into its state-of-the-art drug discovery facility in South San Francisco. The new facility provides FivePrime with a two fold increase in square footage without significant incremental rental cost. The relocation includes an expanded laboratory facility for the Company to accelerate its innovative and proprietary protein therapeutic and antibody drug discovery platform.
Using a molecular cellular compass, individual cells in complex organisms know which way is up or down, in epithelial cells known as apical-basal polarity.
Analysis of the gut microbiome more successfully distinguished healthy individuals from those with precancerous adenomatous polyps and those with invasive colorectal cancer compared with assessment of clinical risk factors and fecal occult blood testing, according to data published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
› Verified 2 days ago
Dr. Adam Greenlee, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 617 Riverside Ave, Burlington, VT 05401 Phone: 802-864-6309 Fax: 802-860-4313 | |
Robert E Gramling, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Uvm Medical Center - Palliative Care Services, Burlington, VT 05401 Phone: 802-847-4848 Fax: 802-847-2929 | |
Dr. Jon Kevin Porter, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 425 Pearl St, Burlington, VT 05401 Phone: 802-656-3350 Fax: 802-656-8178 | |
Robert A Penney, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 789 Pine St, Burlington, VT 05401 Phone: 802-864-0693 Fax: 802-860-6613 | |
David A Reisman, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 | |
Dr. Katherine M Mariani, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3 Timber Lane, Uvm Medical Center-adult Primary Care, S. Burlington, Burlington, VT 05401 Phone: 802-847-8500 Fax: 802-847-6140 |